About Paragon Bioservices
Paragon Bioservices is a Healthcare company based in Baltimore (United States) founded in 1990, and was acquired by Catalent in April 2019. Therapeutic proteins, disease biomarkers, vaccines and reagents for diagnostics. Paragon Bioservices has raised $22.9 million across 5 funding rounds from investors including Catalent, Clinipace Worldwide and Eagle Private Capital. Paragon Bioservices offers products and services including Plasmid DNA, AAV Platform Process, CGMP Manufacturing, and UpTempoâ„ Antibody Platform. Its focus areas include Biopharma Outsourcing, CDMO and Biologics. Its legal entity is Catalent, Inc. Its competitors include KBI Biopharma, Aldevron and Omnia Biologics; 2 of its 3 listed competitors have raised funding.
Company details
Paragon bioservices is a contract research and manufacturing company developing and producing monoclonal antibodies, therapeutic proteins, disease biomarkers, vaccines and reagents for diagnostics and thereby expanding capabilities of partnering pharmaceutical and biotech companies. Research services offered include recombinant protein expression and purification, virus production and purification, virus-like particles and other analytical services. GMP manufacturing services include product development, master and working cell and virus banks, microbial, cell culture, virus production, aseptic fill finish, stability studies, quality control and quality assurance.
Products & Services of Paragon Bioservices
Paragon Bioservices offers a comprehensive portfolio of products and services, including Plasmid DNA, AAV Platform Process, CGMP Manufacturing, and UpTempo℠ Antibody Platform.
Manufacturing of plasmid DNA for gene therapy applications
Process for developing adeno-associated virus vectors
Good manufacturing practices for biologics and therapies
Platform for antibody production processes
Apps and channels of Paragon Bioservices
its YouTube channel Catalent Pharma Solutions has 7.59K subscribers and 30 videos.
Videos from Paragon Bioservices
The most watched videos on Paragon Bioservices's YouTube channel, Catalent Pharma Solutions (7.59K subscribers). Click a video to play it here.
More on Catalent Pharma Solutions.
Funding Insights of Paragon Bioservices
Paragon Bioservices has successfully raised a total of $22.9M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $22.9M
- Total Rounds 5
- Last Round Series A — $5M
- First Round $13.5M
(Nov 2014)
- Investors Count 3
All 5 funding rounds of Paragon Bioservices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $5M | Series A | – | – | – |
| Aug 2018 | Series A | – | – | ||
| May 2017 | $2.4M | Series A | – | – | – |
| Aug 2015 | $2M | Series A | – | – | – |
| Nov 2014 | $13.5M | Series A | – | – |
5 investors in total: 5 institutional.
Investors in Paragon Bioservices
Paragon Bioservices has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Catalent, Clinipace Worldwide and Eagle Private Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Eagle Private Capital is engaged in mezzanine financing and private equity investments. | eagleprivatecapital.com | St. Louis, United States | ||
Investment firm focusing on lower-middle market growth, healthcare, and various strategies. | newspringcapital.com | |||
Growth equity investments are made in lower middle market companies. | 1995 | camdenpartners.com | Owings Mills, United States | |
CDMO offering drug and biologics development services | 2007 | catalent.com | Somerset, United States | |
Full-service digital CRO operations and TEMPO eclinical platform are offered. | 2003 | clinipace.com | Morrisville, United States |
Investor details for Paragon Bioservices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Paragon Bioservices
5 dated milestones of Paragon Bioservices across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Paragon Bioservices is founded.
- Exit Acquired by Clinipace Worldwide.
- Funding First funding round of $13.5M.
- Funding Latest funding round, Series A, of $5.0M.
- Exit Acquired by Catalent.
Competitors of Paragon Bioservices
Paragon Bioservices has 3 listed competitors in our database, 2 of them funded. They include KBI Biopharma, Aldevron and Omnia Biologics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kbibiopharma.com | 1996 | Durham, United States | $17M | 1,243 | Provider of protein formulation, process & cell line development, and cGMP services | |
| aldevron.com | 1998 | Fargo, United States | 747 | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications | ||
| omniabio.com | 2001 | Rockville, United States | $25.4M | Process development and manufacturing services for biologics are provided. |
Detailed competitors of Paragon Bioservices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Paragon Bioservices
Websites that share an audience with Paragon Bioservices (paragonbioservices.com).
Websites whose visitors overlap most with Paragon Bioservices. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mhm-services.com | 100% | View details | |||
| copdfoundation.org | 96% | 167.3K | #131,706 | View details | |
| rehab.com | 95% | 169.5K | #292,501 | View details | |
ulmanfund.org | ulmanfund.org | 94% | – | ||
lifesdha.com | lifesdha.com | 94% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Paragon Bioservices
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Paragon Bioservices (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Paragon Bioservices
Complete news archive for Paragon Bioservices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragon Bioservices
Paragon Bioservices was founded in 1990 and raised its 1st funding round 24 years after it was founded.
Paragon Bioservices is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Paragon Bioservices is a funded company, having raised a total of $22.9M across 5 funding rounds to date. The company's 1st funding round was a Series A of $13.5M, raised on Nov 2014.
Paragon bioservices is a contract research and manufacturing company developing and producing monoclonal antibodies, therapeutic proteins, disease biomarkers, vaccines and reagents for diagnostics and thereby expanding capabilities of partnering pharmaceutical and biotech companies. Research services offered include recombinant protein expression and purification, virus production and purification, virus-like particles and other analytical services. GMP manufacturing services include product development, master and working cell and virus banks, microbial, cell culture, virus production, aseptic fill finish, stability studies, quality control and quality assurance.
Paragon Bioservices's top competitors include KBI Biopharma, Aldevron and Omnia Biologics.
Paragon Bioservices offers Plasmid DNA, AAV Platform Process, CGMP Manufacturing, and UpTempoâ„ Antibody Platform.
Paragon Bioservices has 5 investors. Key investors include Catalent, Clinipace Worldwide, Eagle Private Capital, NewSpring Capital, and Camden Partners.
Paragon Bioservices operates through Catalent, Inc.
Yes. Paragon Bioservices was acquired by Catalent in April 2019.